-
The expanding roles of ITAM adapters FcRgamma and DAP12 in myeloid cells.
Immunol RevHamerman JA, Ni M, Killebrew JR, Chu CL, Lowell CA -
Organization of hyaluronan and versican in the extracellular matrix of human fibroblasts treated with the viral mimetic poly I:C.
J Histochem CytochemEvanko SP, Potter-Perigo S, Johnson PY, Wight TN -
Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10.
J ImmunolIgyarto BZ, Jenison MC, Dudda JC, Roers A, Müller W, Koni PA, Campbell DJ, Shlomchik MJ, Kaplan DH -
Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts.
Cancer ResJandus C, Bioley G, Dojcinovic D, Derré L, Baitsch L, Wieckowski S, Rufer N, Kwok WW, Tiercy JM, Luescher IF, Speiser DE, Romero P -
Preservation of beta-cell function in autoantibody-positive youth with diabetes.
Diabetes CareGreenbaum CJ, Anderson AM, Dolan LM, Mayer-Davis EJ, Dabelea D, Imperatore G, Marcovina S, Pihoker C, SEARCH Study Group. -
TSLP production by epithelial cells exposed to immunodeficiency virus triggers DC-mediated mucosal infection of CD4+ T cells.
Proc Natl Acad Sci U S AFontenot D, He H, Hanabuchi S, Nehete PN, Zhang M, Chang M, Nehete B, Wang YH, Wang YH, Ma ZM, Lee HC, Ziegler SF, Courtney AN, Miller CJ, Sun SC, Liu YJ, Sastry KJ -
The binding of antigenic peptides to HLA-DR is influenced by interactions between pocket 6 and pocket 9.
J ImmunolJames EA, Moustakas AK, Bui J, Nouv R, Papadopoulos GK, Kwok WW -
Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1.
Diabetes CareSosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Mahon J, Greenbaum CJ, Cowie CC, Skyler JS, Diabetes Prevention Trial-Type 1 Study Group. -
Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells.
J Leukoc BiolBollyky PL, Falk BA, Wu RP, Buckner JH, Wight TN, Nepom GT -
Thymic stromal lymphopoietin and the pathophysiology of atopic disease.
Expert Rev Clin ImmunolMiazgowicz MM, Headley MB, Larson RP, Ziegler SF -
Changes in autoreactive T cell avidity during type 1 diabetes development.
Clin ImmunolStandifer NE, Burwell EA, Gersuk VH, Greenbaum CJ, Nepom GT -
CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta.
J ImmunolBollyky PL, Falk BA, Long SA, Preisinger A, Braun KR, Wu RP, Evanko SP, Buckner JH, Wight TN, Nepom GT -
Lineages of human T-cell clones, including T helper 17/T helper 1 cells, isolated at different stages of anti-factor VIII immune responses.
BloodEttinger RA, James EA, Kwok WW, Thompson AR, Pratt KP -
Remodeling rodent models to mimic human type 1 diabetes.
Eur J Immunolvon Herrath M, Nepom GT -
Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years.
Clin ImmunolHerold KC, Gitelman S, Greenbaum CJ, Puck J, Hagopian WA, Gottlieb PA, Sayre PH, Bianchine PJ, Wong E, Seyfert-Margolis V, Bourcier K, Bluestone JA, Immune Tolerance Network ITN007AI Study Group.
